AbbVie Secures FDA Approval for SKYRIZI in Pediatric Psoriatic Disease
NORTH CHICAGO, Ill., June 26, 2026 AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI®...
pediatric medicine
Advertisement
Chiesi Wins EU Approval for Pediatric LOJUXTA Use
PARMA, Italy, June 5, 2026 Chiesi Global Rare Diseases has announced a major regulatory milestone following the European Commission’s...
Foresee Pharmaceuticals Reports Positive CPP Phase 3 Data
TAIPEI, Taiwan, May 27, 2026 Foresee Pharmaceuticals has announced the successful completion of its Casppian Phase 3 clinical trial...
Novartis Coartem Baby Wins WHO Nod for Infant Malaria
BASEL, Switzerland, April 24, 2026 Novartis has achieved a major global health milestone as the World Health Organization (WHO)...
CMP Pharma Introduces Alcohol-Free Norliqva for Pediatrics
FARMVILLE, N.C., April 20, 2026 CMP Pharma, Inc. has announced the availability of a newly reformulated Norliqva® (amlodipine) oral...
Advertisement
